COMP <GO>
LMAT vs UFPT // FREE CASH FLOW YIELD
LeMaitre Vascular Inc. (NASDAQ) VS. UFP Technologies Inc. (NASDAQ) • 15-METRIC TALLY: LMAT 7
— UFPT 6
▲ FREE CASH FLOW YIELD LEADER: LMAT
LAST: $85.27 (+2.90%) • MKT CAP: $1.95B
fcf-yield
4.17%
LAST: $293.30 (+2.55%) • MKT CAP: $2.27B
fcf-yield
4.05%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LMAT VS. UFPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LMAT | UFPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.50% | 28.30% | +43.20 | LMAT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.70% | 13.90% | +0.80 | LMAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.3x | 25.7x | +2.60 | UFPT | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.17% | 4.05% | +0.12 | LMAT | /fcf-yield <GO> |
| Operating Margin | 27.20% | 15.30% | +11.90 | LMAT | /operating-margins <GO> |
| Net Profit Margin | 23.10% | 11.30% | +11.80 | LMAT | /net-margins <GO> |
| Revenue Growth (YoY) | 13.50% | 19.50% | -6.00 | UFPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.93% | 0.00% | +0.93 | LMAT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.30 | 8.31 | -1.01 | UFPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.4 | 44.0 | +1.33 | LMAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.4x | 28.0x | +0.40 | UFPT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.95B | $2.27B | -$321.8M | UFPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LMAT REV | UFPT REV | LMAT GROSS % | UFPT GROSS % | LMAT FCF | UFPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $249.6M | $602.8M | 71.5% | 28.3% | $81.3M | $91.9M |
| FY 2024 | $219.9M | $504.4M | 68.6% | 29.1% | $44.1M | $56.9M |
| FY 2023 | $193.5M | $400.1M | — | — | $36.8M | $41.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LMAT // BETA —
UFPT // BETA —